Activists want 'imminent retirement' of Ariad CEO
February 20, 2015 at 11:24 AM EST
Activist hedge fund Sarissa Capital will nominate two directors to Ariad Pharmaceuticals' board and seek the "imminent retirement" of Chief Executive Harvey Berger.
